Most proteins in the secretory pathway are translated, folded, and subjected to quality control at the endoplasmic reticulum (ER). These processes must be flexible enough to process diverse protein conformations, yet specific enough to recognize when a protein should be degraded. Molecular chaperones are responsible for this decision making process. ER associated chaperones assist in polypeptide translocation, protein folding, and ER associated degradation (ERAD). Nevertheless, we are only beginning to understand how chaperones function, how they are recruited to specific substrates and assist in folding/degradation, and how unique chaperone classes make quality control "decisions".
synthesized proteins are delivered to their final cellular destinations via this pathway [1] . After translation is initiated in the cytosol, the ribosome-nascent chain complex docks at the Sec61 translocon in the ER membrane and protein synthesis resumes. Soluble proteins are translocated into the ER lumen, whereas transmembrane proteins are cotranslationally integrated into the lipid bilayer [2] . Proteins that contain an Asn-X-Ser/Thr sequence are glycosylated by oligosaccharyl transferase as the polypeptide emerges from the translocon. Next, the protein will fold properly and traffic to its final destination, or if folding is inefficient the protein can be targeted for ER associated degradation (ERAD) by the cytosolic proteasome [3] [4] [5] [6] [7] . These three events: protein translocation, protein folding, and protein degradation, are each facilitated by a group of factors termed molecular chaperones.
Before the ribosome-nascent chain complex even docks at the ER, molecular chaperones play an important role in ER physiology: The ER lumenal Hsp70 chaperone, BiP, maintains the permeability barrier between the cytosol and the ER lumen by gating the Sec61 translocon [8, 9] . Next, as translocating proteins leave the translocon, folding and post-translational modifications are mediated by a collection of chaperones and enzymes. Three major groups of ER chaperones act on the nascent chain, the heat shock protein homologues (e.g., Hsp70, Hsp40, Hsp90), the ER lectins (e.g., calnexin, calreticulin), and the thiol oxidoreductases (e.g., PDI). Several ER lumenal heat shock protein homologues prevent protein aggregation and promote folding. Similarly, the ER lectins bind to immature glycoproteins to promote substrate folding and will retain proteins in the ER in the event folding is compromised. The thiol oxidoreductase proteins mediate proper disulfide bond formation and may also act as chaperones. Because transmembrane proteins have domains exposed in the ER lumen, in the cytosol, and in the membrane, this group of proteins may interact with factors in each of these compartments. For example, a different set of chaperones is responsible for recognizing the defect and targeting the protein for degradation depending upon where the folding lesion is located within the protein [6, 10, 11] .
The same chaperones involved in "folding" the substrate may also trigger its proteolysis. In fact, all three chaperone classes are involved in targeting proteins for degradation in addition to catalyzing folding. Not surprisingly, many diseases are linked to defects in the ER associated quality control machinery (ERQC). For example, cystic fibrosis, antitrypsin deficiency, Alzheimer's disease, Huntington's disease, and nephrogenic diabetes insipidus result when specific proteins either fail to fold properly and are targeted for degradation, or are hidden from the degradation machinery and accumulate as toxic aggregates [12, 13] .
In most cases, the accumulation of misfolded proteins in the ER leads to the activation of the unfolded protein response (UPR). In yeast, misfolded proteins in the ER are sensed by the transmembrane kinase, Ire1, which when activated promotes the splicing of the message for the Hac1 transcription factor. Hac1 regulates the transcription of UPR targets that include chaperones and ERAD effectors. In mammals, the ER sensor, ATF6, upregulates the synthesis of ER chaperones, and the ER transmembrane kinase PERK activates the synthesis of the ATF4 transcription factor but triggers a general inhibition of translation. Along with activation of Ire1, these cascades reduce the overall protein load in the mammalian secretory pathway. If, however, this load cannot be decreased, ATF4 and ATF6 dependent apoptosis may ensue [14] [15] [16] .
Molecular chaperones, chaperone-like proteins, and their roles during protein biogenesis in the ER
In this section we describe the major classes of chaperones, cochaperones, and chaperone-like proteins that act on substrates in the ER. Because of their role in ER homeostasis, we will focus our discussion on eukaryotic systems. Due to space constrictions select examples in the literature will be highlighted.
Hsp70s
Members of the Hsp70/Hsc70 class of molecular chaperones are essential for protein folding, membrane translocation, disrupting protein aggregates, and rearranging multiprotein complexes. Indeed, Hsp70s are perhaps the best-studied class of chaperones [17] . Hsp70s are highly conserved and are found in all organisms. Hsp70 function and specificity are highly regulated by cochaperones such as Hsp40s and nucleotide exchange factors (NEFs) (described below).
All Hsp70s are composed of three domains, an ∼44 kDa N-terminal ATPase domain, an ∼15 kDa substrate-binding domain, and an ∼10 kDa C-terminal lid [18] [19] [20] . The extreme C-terminus contains an EEVD motif that interacts with cochaperones that possess degenerate 34 amino acid tetratricopeptide repeats (TPRs). Crystallographic studies of bovine Hsc70 (see below) show that the ATPase domain contains two globular lobes, which are separated by a deep ATP-binding cleft [18] . A change in the tertiary structure of this domain is seen when ATP or ADP is bound in the active site [21] . The structure of the substrate-binding domain was first determined for the E. coli Hsp70, DnaK, and is primarily composed of ␤ sheets that bind the hydrophobic peptide substrate [19] . The substrate is sequestered by, but does not interact with the ␣ helical lid [19] , but directly interacts with the substrate-binding domain in an extended conformation.
Hsp70s function by binding substrates and using the energy from ATP hydrolysis to influence substrate binding. The unstimulated rate of ATP hydrolysis is slow and ranges from 0.02 to 0.2 min −1 [22] [23] [24] . When Hsp70 is found in the ATP bound state, the lid is open and substrates have a low affinity for the peptide-binding domain, resulting in a high on/off rate. However, substrate-binding significantly stimulates Hsp70 ATP hydrolysis and causes the lid to clamp down onto the substrate [25, 26] . When ADP is bound the substrate interacts with the peptide-binding domain with high affinity, and thus has a low on/off rate [24, 27] . After ADP is released, the Hsp70 rebinds ATP, the lid domain opens, and the peptide dissociates [28, 29] .
Nucleotide-and substrate-induced conformational changes in Hsp70 are becoming better defined and in one recent example were shown to require a proline at residue 143 and an arginine at residue 151 in the DnaK ATPase domain [30] . It has been proposed that ATP binding is relayed to the substrate-binding domain via the proline, most likely by a cis-trans isomerization, which then shifts the arginine toward the peptide-binding domain. When substrate binds to the peptide-binding domain and Hsp40 (see below) interacts with the ATPase domain, the arginine is moved inward and the conformation of the proline is altered. This conformation positions residues in the ATPase domain to facilitate ATP hydrolysis [30] . The coupling between the ATPase and substrate-binding domains is also dependent on the movement of an interdomain linker. Overall, it is likely that a continued refinement of the ATP-dependent conforma-tional changes will better elucidate how this intricate machine functions [31] .
For most Hsp70s ATP hydrolysis represents the rate-limiting step [23, 24] . In addition to peptide stimulation, the Hsp70 ATPase cycle is stimulated by cochaperones such as the Hsp40s and NEFs. Hsp40s stimulate ATP hydrolysis [32] [33] [34] , whereas NEFs aid in the release of ADP [35, 36] . Thus, these cofactors and the bound substrate function together to regulate Hsp70 function. The NEFs and Hsp40s will be discussed in subsequent sections.
Both the cytosolic and ER lumenal Hsp70s affect protein biogenesis at the ER. As noted above, the ER lumenal Hsp70, BiP/Kar2 may gate the translocon and is therefore required for the co-and post-translational translocation of proteins into the ER [8, 9] . As the nascent chain emerges from the ribosome, or during post-translational translocation, BiP binds the chain and promotes translocation through a ratcheting mechanism [37] . As the chain continues to lengthen and increasing polypeptide lengths enter the ER, BiP "holds" the nascent chain in the ER and prevents it from moving back into the cytoplasm. Mathematical modeling suggests that Brownian motion and the action of BiP is a plausible mechanism for translocation [38] . Further, in vesicles lacking BiP, antibodies that bind the peptide chain during translocation can replace BiP, suggesting that protein-binding alone is sufficient to facilitate translocation [37] .
Upon the completion of translation, BiP assists in protein folding in the ER. For example, unfolded carboxypeptidase Y (CPY), a soluble protein targeted to the vacuole in the secretory pathway, fails to mature in yeast strains with mutations in BiP; instead, CPY is recovered in high molecular weight aggregates associated with BiP [39] . Mutations that decrease BiP ATPase activity increase the BiP-CPY association, and because the mutant BiP does not release CPY, folding is inefficient [39] . More recently, it has become apparent that BiP's role in protein folding may be coordinated with Lhs1, a distant Hsp70 homologue in the ER lumen [40] . BiP and Lhs1 reciprocally stimulate each other's ATPase activity, and Lhs1 acts as an NEF for BiP [40] . Both proteins are necessary for protein folding in the ER, and BiP and Lhs1 may alternatively and/or sequentially bind unfolded proteins since the substrate specificities of different classes of Hsp70s are variable [40, 41] . In support of this hypothesis, BiP and the mammalian Lhs1 homolog, GRP170, were both found to associate with unfolded immunoglobulin chains [41, 42] .
In the event that unfolded proteins accumulate in the ER lumen, the UPR is activated. In one model, under nonstressed conditions BiP binds to the lumenal domain of Ire1, but under stressed conditions BiP is titrated away from this UPR transducer by misfolded proteins. This results in the activation of both Ire1 and consequently the UPR [43, 44] . Alternatively, more recent studies suggest that BiP may play only an indirect or regulatory role in UPR induction because deleting or mutating the BiP-binding region in Ire1 had little effect on Ire1's response to unfolded proteins [45] . In addition, a recent crystal structure of the lumenal domain of yeast Ire1 suggests that this UPR sensor binds directly to unfolded proteins [46] . ER lumenal Hsp70s are not only important for protein folding and sensing the UPR, but also for targeting soluble proteins for ERAD. For example, yeast BiP (Kar2) is required for the degradation of the soluble ERAD substrate, CPY*, because it retains CPY* in a soluble conformation [47] . In accordance with this result, a BiP mutant that is proficient for translocation but deficient for ERAD leads to the accumulation of unfolded proteins in the ER and UPR induction [48] . Therefore, the roles BiP plays in translocation and targeting proteins for degradation are distinct.
The cytosolic Hsp70s are also conserved and fall into two classes: Hsp70s, which are stress-inducible and Hsc70s, which are constitutively expressed Hsp70 homologues. Historically, the major difference between Hsps and Hscs was thought to be their mode of expression. However, recent work has shown that Hsp70 and Hsc70 have different effects on the biogenesis of membrane-spanning proteins. Whereas Hsc70 decreased the functional expression of the epithelial sodium channel, ENaC, Hsp70 had the opposite effect and promoted the surface expression of the channel [49] . Along with its cofactors, Hsc70 was also proposed to facilitate the early biogenesis of CFTR whereas Hsp70 may be important for ERAD [50] . It was suggested that the Hsc70 chaperone complex functions by stabilizing CFTR's large cytoplasmic domains during translation, and consistent with this model Hsc70 and its cochaperones coprecipitate with newly translated CFTR [51] .
The ERAD of most membrane-spanning proteins does not require the ER lumenal Hsp70s, but does require the cytosolic Hsp70s. For example, the degradation of CFTR was inhibited in yeast strains with mutations in the cytosolic Hsp70, Ssa1. In contrast, there was no effect on CFTR degradation in strains with mutations in BiP [52] . Integral membrane ERAD substrates that require neither the cytosolic nor lumenal Hsp70s have also been identified [11] .
Hsp40s
Members of the Hsp40 class of chaperones can act as Hsp70 cochaperones. Although their best-defined role is to stimulate Hsp70 ATP hydrolysis, some Hsp40 homologues also have a substrate-binding domain and deliver substrates to Hsp70s [53] [54] [55] [56] [57] . The prototypical Hsp40 is the E. coli DnaJ [32] . All Hsp40s contain a J domain, named for a conserved ∼70 amino acid motif in DnaJ, and are often referred to as J domaincontaining proteins or J-proteins. The structures of several J domains have been elucidated and indicate the presence of four alpha helices [58] . Helices II and III interact to form a finger-like projection and the loop between Helices II and III contains an invariant HPD motif, which is essential for stimulating Hsp70 ATP hydrolysis. DnaJ is a type I Hsp40, and contains an N-terminal J domain, a glycine/phenylalanine-rich domain (G/F), and a cysteine-rich domain. In contrast, type II Hsp40s lack a cysteine-rich domain, but generally have a longer glycine/phenylalanine rich domain. These differences may dictate substrate specificity [59] . A third class of J domaincontaining proteins, the type III proteins, contains only the J domain, and may employ this domain to recruit Hsp70.
The Bukau lab determined that DnaJ preferentially binds short polypeptides that are enriched for aromatic and/or hydrophobic residues [55] . But, between similar Hsp40s some degree of divergence in peptide substrate has been observed [59] . The preferred peptides for Hsp40 are slightly different than Hsp70 [60] , but most peptides that bind to Hsp40 also bind to Hsp70 and two hypotheses for substrate transfer from Hsp40 to Hsp70 have been proposed [55] . The "handover" mechanism suggests that Hsp70 displaces Hsp40 from the substrate and binds the same residues. A second hypothesis proposes that Hsp40 and Hsp70 bind residues in close proximity and each protein occupies discrete positions on the substrate simultaneously, which has been experimentally verified for select substrates [53] .
Because each cell contains multiple Hsp70s and Hsp40s, the nature of substrate-specific interactions involving individual Hsp70 and Hsp40 is mysterious. Some degree of specificity is certainly created simply by compartmentalization. Membrane enclosed compartments such as the ER and mitochondria have dedicated Hsp70s and Hsp40s, which are physically separated from the cytosolic chaperones. However, specificity is also seen within a single compartment. For example, the yeast cytosolic Hsp70, Ssa1, is stimulated ∼6-fold by a cytosolic partner, Ydj1, but only 1.5-fold by the J domain of Sec63, which resides in the ER lumen. Similarly, BiP is stimulated ∼13-fold by the Sec63 J domain, but only 1.4-fold by Ydj1 [61] . J domain swapping experiments have also been performed to address Hsp70/Hsp40 specificity [58] . These studies have shown that not all J domains can functionally substitute for each other and that J domains must encode information for interaction specificity. J domain swaps between the yeast cytosolic J-protein, Sis1, mitochondrial J-protein, Mdj1, and the ER lumenal J-protein, Scj1, with Sec63 were performed and indicated that the J domains of mitochondrial Mdj1p and cytosolic Sis1 do not substitute for the ER lumenal Sec63 J domain. However, ER lumenal Scj1 functionally substituted for Sec63, which is perhaps not surprising since both proteins interact with BiP [62] . In some J-proteins the J domain appears sufficient to dictate specificity. For example, the exposed regions of specific type III J-proteins (e.g., polyomavirus tiny tumor antigen (tAg) and Sec63) are extremely short. Despite its size, the Sec63 J domain allows productive interactions with BiP, but not cytoplasmic Hsp70, Ssa1 [61] . However, none of these studies rule-out the possibility that residues beyond the J domain play an additional role in determining specificity.
The Hsp40 Sec63 acts as a cochaperone for BiP to facilitate translocation into the ER lumen [63] . But, BiP interacts with two other ER lumenal Hsp40s, Scj1 and Jem1, to retain proteins in a soluble conformation [47, 64] . In the event that a soluble, secreted protein fails to mature, Scj1 and Jem1 are also required for ERAD. In contrast, these lumenal Hsp40s have no effect on the ERAD of membrane-spanning proteins that have been examined, but in mammals the cytosolic Ydj1 homologue, Hdj2, acts a cochaperone for Hsc70 to facilitate early folding events during the biogenesis of CFTR. The Hsc70-Hdj2 complex associates at ∼2-fold higher levels with the disease-causing, mutant form of CFTR ( F508 CFTR) than WT CFTR, which is consistent with the fact that F508 folds less efficiently than WT. Further evidence that this complex plays a role in folding is its ability to maintain the solubility of a large, cytoplasmic nucleotidebinding domain in CFTR during the translation of the C-terminal portion of the protein [51] (also see Fig. 1 ). Overexpression of another cytosolic Hsp40, Csp, in CFTR expressing cells blocks CFTR maturation by "holding" it in the ER where it will either complete folding or be subjected to ERAD [65] . Similarly, the cytosolic Hsp40s, Ydj1 and Hlj1, in yeast function redundantly to promote CFTR degradation in yeast [66] . Overall, it is clear that Hsp40s are important mediators of ERQC but the rules governing whether distinct Hsp40s help fold and/or degrade a given substrate have yet to be defined.
Nucleotide exchange factors (NEFs)
In the presence of a J domain containing protein, the ratelimiting step in the Hsp70 cycle becomes the release of ADP [67] . Not surprisingly, then, NEFs have evolved to enhance the liberation of ADP from Hsp70s. ATP preferentially rebinds because of its higher intracellular concentration. Interestingly, three structurally distinct Hsp70 NEFs have been identified, GrpE in bacteria, and BAG-1 and HspBP1 in eukaryotes. Also, recent studies have shown that the yeast Hsp110 homologue, Sse1, acts as a NEF for Ssa1 [68, 69] , and is likely to enhance ADP release through yet another mechanism. Each of these factors is considered below.
GrpE was the first Hsp70 NEF identified and acts on DnaK. GrpE homologues have only been identified in bacteria and eukaryotic organelles of prokaryotic origin, such as the mitochondria [35] . GrpE was discovered as a protein required for phage replication [70] that removes both ADP and ATP from DnaK [71] , though the affinity of GrpE for DnaK is decreased in the presence of ATP [72] . GrpE crystallizes as a dimer, which is consistent with the observed 1:2 ratio of DnaK to bound to GrpE [73, 74] . GrpE interferes with nucleotide binding by loosening the conformation of DnaK's ATPase domain.
The mammalian NEF, BAG-1, was first identified as a Bcl-2 associated athanogene, which binds anti-apoptotic Bcl-2 and was then discovered to associate with other proteins, including Hsp70 [75] . All of the functions of BAG-1 in the cell are currently unclear, but BAG-1 has convincingly been shown to be a NEF for Hsp70 [76] . A BAG-1 homologue, Snl1, has been identified in S. cerevisiae, which interacts with cytosolic Hsp70s and stimulates nucleotide exchange [77] . The BAG domain is required for NEF activity, and is structurally distinct from GrpE [78] . Unlike GrpE, BAG-1 is selective and only releases ADP from Hsp70 [71] . Interestingly, BAG-1 has differing effects on Hsp70 substrate folding, depending on the Hsp70:BAG-1 stoichiometry [79] .
A third NEF class is exemplified by the Hsp-binding protein 1, HspBP1, which was first identified as a cytosolic inhibitor of Hsp70 refolding at high concentrations [80] . As with BAG-1 it now appears that HspBP1 also facilitates protein folding when the HspBP1:Hsp70 ratio is adjusted [81] . Two other HspBP1 homologues have been identified, Fes1 in the yeast cytosol and BAP in the mammalian ER [82, 83] . Interestingly, Fes1 is an NEF for two yeast cytosolic chaperones. In addition, fes1 cells are sensitive to cycloheximide, an inhibitor of protein translation, and contain somewhat increased levels of 80S ribosomes relative to wild-type cells [82, 84] . Taken together, these results suggest that Fes1 may be important for folding newly synthesized polypeptides as they exit the ribosome. These NEFs are structurally distinct from GrpE and BAG-1 and utilize a unique mechanism of action [85] .
As noted above, the yeast Hsp110 molecular chaperone, Sse1, was shown to exhibit nucleotide exchange activity [68, 69] . Hsp110s are distantly related to Hsp70s and have similar N-terminal ATPase domains, but the C-terminal, putative substrate-binding domain is not homologous to Hsp70. In addition, Hsp110s have extended regions between the ATPase and C-terminal domains and at the extreme C-terminus [86, 87] . Hsp110 acts as a holdase, and prevents protein aggregation but cannot catalyze protein folding [88] . Sse1 is found in chaperone complexes with yeast Hsp90 and Hsp70 [89, 90] . A role in Hsp70 function was hinted at by the discovery of SSE1 as a multi-copy suppressor of the ydj1-151 thermosensitive allele of the yeast Hsp40, YDJ1 [91] . This suggested that Sse1, like Ydj1, stimulates the Hsp70 ATP hydrolysis cycle. In fact, Sse1 stimulates the steady state ATPase activity of Hsp70, but does not stimulate Hsp70 in single turnover ATPase assays, suggesting it is involved in nucleotide release. Fluorescent ADP-Hsp70 release assays in the presence Sse1 confirmed this hypothesis [68] . Sse1 also stimulates substrate release from Hsp70 [84] . While Sse1 cannot fold a model substrate independently, it stimulates folding in the presence of Hsp70 in vivo and in vitro [68, 84] . To date, a role for Sse1 in ERAD has only been established for one substrate, apolipoprotein B (apoB). In a yeast model system, loss of Sse1 led to decreased ERAD of the lipoprotein, and over-expression of Hsp110 increased apoB secretion from hepatic cells. Therefore, Sse1 seems to be important for stabilizing apoB [92] .
Although cellular roles for NEFs are still being defined, the data discussed above suggest that NEFs play varied roles in protein biogenesis. Consistent with this view, HspBP1 stimulates CFTR folding, possibly by inhibiting the binding of a ubiquitin ligase, CHIP [93] . CHIP, in association with Hsc70, targets CFTR for proteasome-mediated degradation. In contrast, BAG-1 facilitates CFTR degradation by stimulating the Hsc70-CHIP complex [94, 95] . Thus, distinct NEFs can play opposing roles during the biogenesis of a given substrate.
Hsp90s
Hsp90s, like Hsp70s, bind and release substrates concomitant with ATP binding/hydrolysis. However, unlike Hsp70s and Hsp40s, which are involved in folding newly synthesized polypeptides, Hsp90s fold a specific set of client proteins that have neared their native conformations (http://www.picard.ch/ downloads/Hsp90interactors.pdf). Specifically, Hsp90 is responsible for activating proteins or holding them in a conformation conducive for interaction with required hormones or other proteins. Prominent Hsp90 clients include hormone receptors, protein kinases, and transcription factors [96] . Hsp90 homologues reside in bacteria, yeast, and human cells, and in humans include the cytoplasmic Hsp90␣ and Hsp90␤ proteins and mitochondrial and ER forms [97] .
Hsp90s contain a ∼25 kDa N-terminal ATP-binding domain, a middle region, and a C-terminal ∼12 kDa domain. The ATP-binding domain contains an ATP-binding pocket, which also binds the competitive inhibitor, geldanamycin, and other ansamycin antibiotics. Hsp90 contains a split ATPase domain, and ATPase activity requires dimerization. The middle region contains an acceptor site for the ␥ phosphate of ATP and may aid in the removal of the ␥ phosphate during ATP hydrolysis [98] , and a large hydrophobic patch that is responsible for client protein binding [98] . The C-terminal domain is dedicated to Hsp90 dimerization [99, 100] .
In the nucleotide free state, the Hsp90 dimer exists in the "open" conformation in which the N-terminal ATP-binding domains are separated and client proteins interact in the region between the two dimers. However, upon ATP binding, the Nterminal domains interact and form a "closed" state around the client protein. Hsp90 has a weak ATPase activity [101] [102] [103] and many cochaperones, including Hsp70 and Hsp40, are required for Hsp90 function. Other cochaperones either enhance or inhibit Hsp90 ATPase activity. Components of the Hsp90 complex can differ depending on the nature of the bound substrate, but after ATP hydrolysis, client proteins are released and Hsp90 is recycled.
The role of Hsp90 during protein biogenesis in the ER has been difficult to reconcile with a single mechanism of action. Blocking the association between Hsp90 and CFTR using geldanamycin accelerated CFTR degradation [104] . Consistent with this result, studies in yeast showed that Hsp90 is required for the folding/stabilization of CFTR and a related, misfolded yeast, Ste6p* [66, 105] . In contrast, Hsp90 promotes the degradation of apoB [106] . A recent study by Wang et al. [107] demonstrated that the Hsp90 cochaperone, Aha1, which enhances the ATPase activity of Hsp90, is crucial for retaining the F508 mutant form of CFTR in the mammalian ER. When Aha1 expression was reduced by siRNA the defects in trafficking and plasma membrane expression of F508 CFTR were rescued, which suggests a role for Hsp90 not only in folding but in acting as a gate-keeper for ER exit.
Thiol oxidoreductases
The thiol oxidoreductases are an ER localized class of chaperone-like enzymes that are involved in disulfide bond formation, protein folding, and recognizing and targeting aberrant proteins for ERAD [108] [109] [110] . The best studied thiol oxidoreductase is PDI (protein disulfide isomerase). PDI is a ∼110 kDa homodimeric protein that is widely distributed and makes up nearly 2% of the total protein content of the ER [111] . The mammalian ER has at least 17 disulfide isomerases, 9 of which have been shown to participate in the formation of disulfide bonds through redox reactions (Table 1 ) [112] . The family of PDI-like proteins is characterized by the presence of catalytic CxxC active site motif. The sequence and number of these domains varies among family members. The crystal structure of yeast PDI revealed that the protein has a twisted U shape with two inactive catalytic sites between the two active thioredoxin domains that face one another [113] . The interior of the "U" is hydrophobic and is most likely responsible for binding hydrophobic stretches on unfolded proteins [113] , which probably explains why PDI has an essential chaperonelike function [114, 115] . The structure also predicts that the C-terminal tail stabilizes one of the catalytically active domains. This is in contrast to mammalian PDI, which is predicted to possess a C-terminal tail that does not seem to play a critical role in enzyme activity [116, 117] .
Unlike the cytosol, the ER provides an oxidative environment for disulfide bond formation. Therefore, to catalyze disulfide bond formation PDI must be maintained in an oxidized state, which is accomplished by Ero1 [118, 119] . Ero1 then passes electrons to molecular oxygen via FAD, potentially creating reactive oxygen species (ROS). These ROS can give rise to a significant degree of oxidative stress and even induce the UPR if the level of PDI substrates is high. The yeast ER has one Ero1 and mam-mals have two isozymes, Ero1␣ and Ero1␤. Ero1␣ is induced by hypoxia and may play a role in ERAD [120, 121] whereas Ero1␤ is induced by the unfolded protein response [122] .
It is currently unknown why there are so many PDIs in the ER. One proposal is that these serve as sources of oxidative equivalents, or participate in an oxidative relay [123] . However, it has been shown that the oxidative activities of five different PDIs are very similar, suggesting that they are not dependent upon one another [124] . Other explanations are that specialized PDI members act on unique substrates, or the PDIs act sequentially. For example, the transmembrane TMX proteins may preferentially act on membrane spanning substrates, and ERp57 may interact preferentially with glycoproteins bound to CNX/CRT [125, 126] . In contrast, PDI works alone or with BiP [127, 128] . Recent work by Forster et al. demonstrated that two PDI family members have opposite effects on cholera toxin protein: PDI promoted the unfolding and subsequent retrotranslocation of cholera toxin A and A1 chains whereas ERp72 promotes folding [129, 130] .
A role for a yeast PDI homologue in a specific aspect of ERQC has also been uncovered. Eps1 is an ER membrane, PDI-like, protein. In strains deleted for EPS1 a mutant plasma membrane [H+]ATPase was not ER retained, but trafficked to the cell surface. When Eps1 is expressed, the ATPase is degraded. These data suggest that Eps1 acts as a novel chaperone-like protein to block the trafficking of mutant Pma1 and can target the protein for ERAD [131] . More generally, these data suggest that specialized roles for other PDI homologues are likely to exist in both yeast and mammals.
AAA ATPase
The AAA ATPase p97 (Cdc48 in yeast) is a homohexameric ring that is involved in diverse cellular processes, including membrane fusion [132, 133] , activation of membrane associated transcription factors [134] , spindle disassembly [135] , apoptosis [136] , and ERAD [137] [138] [139] . Interestingly, p97 binds distinct co-factors that specifies its function. The AAA proteins contain two ATP-binding domains, D1 and D2 domains, and a ∼200 residue N-terminal domain (N) that varies among the AAA proteins. Multiple mechanisms for p97 function have been proposed based on the structures of p97 and other AAA proteins. The "molecular ratchet" model suggests that p97 uses ATP-driven conformation changes to propel substrates that are bound to the N-terminal domain. This model predicts that p97, with one of its cofactors, p47, forms a propeller-like structure [140] . In contrast, the "denaturation-collar" model predicts that secondary structures are unfolded by an inherent denaturation-like activity within a pore. Substrates are then threaded through grooves within this pore [141] .
p97 binds both to ubiquitinated proteins and to the proteasome [142, 143] . Several studies have implicated p97/Cdc48 and two of its potential co-factors, Npl4 and Ufd1, in ERAD [144] . These studies are consistent with p97 providing the energy necessary to extract most proteins for ERAD [137, 138, 143] . Mutations in the yeast Cdc48 ATPase domain block ER export, although at least two ERAD substrates are instead extracted by AAA proteins in the proteasome "cap" [145] [146] [147] . The mechanism for this process is poorly defined. Yeast Cdc48 is tethered to the ER by the transmembrane Ubx2 protein, which links the Cdc48 complex to ubiquitin ligases [148] . Deletion of Ubx2 leads to the stabilization of the soluble ERAD substrate CPY* as well as a membrane spanning substrate [148] . Surprisingly, in cells lacking Ubx2 a significant amount of Cdc48 is still localized to the ER membrane, suggesting that other proteins are involved in tethering. p97 also interacts with a ubiquitin ligase, gp78, at the ER membrane to couple ubiquitination and retrotranslocation [149] . In mammals, Ataxin-3, a deubiquitinating enzyme, was recently identified as a modulator of p97 activity. Ataxin-3 appears to displace Ufd1 and inhibits retrotranslocation by decreasing the interaction between p97 and both Ufd1 and ubiquitinated substrates [150] . These data suggest that p97 plays several roles in the selection and modification of proteins during ERAD.
Lectin-like
The lectin-like class of chaperones recognizes the oligosaccharyl-appended N-glycan to moderate binding and facilitate protein folding and/or ERAD. This class includes calnexin/ calreticulin, Yos9 and the EDEM1-3 proteins. Through cycles of binding and release these chaperones help fold and/or retain misfolded proteins in the ER so that they can be targeted for degradation [151, 152] . Although the lectin-like chaperones will be discussed in detail in another chapter in this volume, it is important to note here that these chaperone-like proteins have been found in multiprotein complexes with other effectors of protein biogenesis and degradation.
Other
Another group of chaperones that has recently been connected to the biogenesis/degradation of ER associated proteins are the cytosolic small heat shock proteins (sHsps). This class of chaperones is widespread, but except for a ∼90 amino acid "␣-crystallin" domain are poorly conserved. Recently, Ahner et al. found that mammalian ␣-crytallin preferentially selected the F508 form of mutant CFTR for degradation over WT CFTR [153] . These studies derived from observations that CFTR expression induced the synthesis of two sHsps in yeast. Because ␣-crystallin maintained the solubility of the first nucleotidebinding domain of CFTR, the sHsps may help deliver F508 CFTR to the proteasome. A recent study by Kashlan et al. also showed that sHsps target the membrane-spanning epithelial sodium channel for degradation [154] .
Membrane-spanning, chaperone-like proteins that exhibit substrate specificity have also been identified in bacteria and yeast [155] [156] [157] . For example, the Ljungdahl group identified four ER membrane-spanning proteins that assist in the folding of unique substrates in yeast. Gsf2, Pho86, Chs7 and Shr3 assist in folding hexose transporters, phosphate transporters, chitin synthase-III and amino acid permeases, respectively. In the absence of their unique chaperones each of these substrates fails to properly fold, forms high molecular weight aggregates, and is ER retained [155, 156] . It remains to be seen if "specialized" chaperones are common in higher eukaryotes as well.
Final comments
The functions of the chaperone classes discussed above are in no way mutually exclusive. In fact, many of these proteins act at the same time or sequentially on the same substrates and have been found in complexes. For example, Meunier et al. identified a chaperone complex associated with unfolded IgG heavy chain that includes BiP (Hsp70), Grp94 (ER Hsp90 homologue), CaBP1 (calcium-binding protein), PDI, ERdj3 (Hsp40), cyclophilin B (peptidyl-prolyl isomerase), ERp72 (thiol oxidoreductase), Grp170 (Hsp110), UDP-glucosyltransferase, and SDF2-L1; BiP, GRP94, and GRP170 exist as a pre-formed complex even in the absence of substrate [42] . The mutant form of ␣ 1 -antitrypsin, ␣ 1 -AT Z is found in a complex with BiP, Grp94, Grp170, UGGT, and calnexin [158] . Complexes similar to these have been found for cytosolic Hsp70 and Hsp90, which together bind unfolded proteins and appear to recruit other chaperones [159] . Together, these studies suggest that chaperones do not work in isolation, but function together as part of a dynamic and complex network of folding and degradation effectors.
What determines the make-up of these complexes is only beginning to be understood. The location and type of protein substrate seems to play some role. For example, the soluble protein, CPY, and the transmembrane protein, CFTR, require different chaperone complements for both their folding and degradation (Fig. 1) . Whereas CPY requires the ER lumenal chaperones BiP, Scj1, Jem1, PDI, and calnexin for folding, CFTR has large domains exposed to the cytosol that require Hsp70, Hsc70, HspBP1, Hdj2, Hsp90 and Aha1 to attain a mature conformation.
It is also unclear precisely how chaperones act as "decision makers" for the ER quality control system. As discussed above distinct chaperone classes have unique effects depending upon the ERAD substrate, and even at times different effects on the same substrate. For example, as shown in Fig. 1 , BiP/Jem1/Scj1 are required not only for the folding of CPY, but for the degradation of the ERAD target, CPY* [47, 64] . Similarly, both Hsp70 and Hsc70 are required for CFTR folding and degradation, although the cochaperones may vary [51, 66, 95] . What, specifically, these chaperones recognize and how they decide whether a protein is properly folded or will be degraded is still unknown, even for these two well-studied proteins.
